Stocks and Investing Stocks and Investing
Thu, September 14, 2023
Wed, September 13, 2023
Tue, September 12, 2023
Mon, September 11, 2023

Eddie Hickman Maintained (TARS) at Strong Buy with Increased Target to $49 on, Sep 11th, 2023


Published on 2024-10-28 06:21:37 - WOPRAI, Eddie Hickman
  Print publication without navigation


Eddie Hickman of Guggenheim, Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy with Increased Target from $46 to $49 on, Sep 11th, 2023.

Eddie has made no other calls on TARS in the last 4 months.



There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, 0 agree with Eddie's Rating of Hold.



This is the rating of the analyst that currently disagrees with Eddie


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Friday, August 11th, 2023